1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-141760S
    N-Acetyl sulfamethazine-d4
    N-Acetyl sulfamethazine-d4 is the deuterium labeled N-Acetyl sulfamethazine.
    N-Acetyl sulfamethazine-d<sub>4</sub>
  • HY-B0455S
    Lomefloxacin-d5 hydrochloride
    99.88%
    Lomefloxacin-d5 (hydrochloride) is the deuterium labeled Lomefloxacin hydrochloride. Lomefloxacin (SC47111A) hydrochloride is a broad-spectrum quinolone antibiotic, with antimicrobial activity. Lomefloxacin hydrochloride is used for the research of respiratory tract infections, genitourinary infections, gastrointestinal infections, ENT infections, etc..
    Lomefloxacin-d<sub>5</sub> hydrochloride
  • HY-109506S3
    DPPC-d9-1
    ≥99.0%
    DPPC-d9-1 is the deuterium labeled DPPC. DPPC (129Y83) is a zwitterionic phosphoglyceride that can be used for the preparation of liposomal monolayers. DPPC-liposome serves effectively as a delivery vehicle for inducing immune responses against GSL antigen in mice.
    DPPC-d<sub>9</sub>-1
  • HY-N7106S
    Dimethyl phthalate (Ring-d4)
    99.73%
    Dimethyl phthalate (Ring-d4) is the deuterium labeled Dimethyl phthalate. Dimethyl phthalate, a known endocrine disruptor and one of the phthalate esters (PAEs), is a ubiquitous pollutant. Dimethyl phthalate is commonly used as a plasticizer to impart flexibility to rigid polyvinylchloride (PVC) resins.
    Dimethyl phthalate (Ring-d<sub>4</sub>)
  • HY-113301S1
    Hexacosanoic acid-d4-1
    98.0%
    Hexacosanoic acid-d4-11 is the deuterium labeled Hexacosanoic acid (HY-113301). Hexacosanoic acid is a very long-chain fatty acid. Abnormally elevated levels of Hexacosanoic acid are closely associated with various diseases, such as X-linked adrenoleukodystrophy, adrenomyeloneuropathy, atherosclerosis, and dementia.
    Hexacosanoic acid-d<sub>4</sub>-1
  • HY-B1438S
    Canrenone-d6
    98.78%
    Canrenone-d6 is the deuterium labeled Canrenone. Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.
    Canrenone-d<sub>6</sub>
  • HY-W013266S
    N4-Acetylsulfamethoxazole-d4
    98.66%
    N4-Acetylsulfamethoxazole-d4 (Acetylsulfamethoxazole-d4) is the deuterium labeled N4-Acetylsulfamethoxazole (HY-W013266). N4-Acetylsulfamethoxazole (Acetylsulfamethoxazole) is the N4-acetylated metabolite of Sulfamethoxazole (HY-B0322).
    N4-Acetylsulfamethoxazole-d<sub>4</sub>
  • HY-B0188S
    Mianserin-d3
    Mianserin-d3 is the deuterium labeled Mianserin (HY-B0188). Mianserin (Mianserine) is an orally active H1 receptor antagonist. Mianserin can activate κ-opioid receptor and octopamine receptor. Mianserin increases ERK1/2 and CREB phosphorylation, and antagonizes full κ-opioid agonist and Dynorphin A (HY-P1333)-induced MAPK phosphorylation. Mianserin modulates social and exploratory behaviour, raises electroconvulsive thresholds. Mianserin can be used for the research of neurological disease, such as depression and epilepsy.
    Mianserin-d<sub>3</sub>
  • HY-B0125S
    Ofloxacin-d3
    99.77%
    Ofloxacin-d3 is the deuterium labeled Ofloxacin.
    Ofloxacin-d<sub>3</sub>
  • HY-B0121BS
    Sumatriptan-d6 succinate
    99.63%
    Sumatriptan-d6 succinate is the deuterium labeled Sumatriptan succinate. Sumatriptan succinate is an orally active 5-HT1 receptor agonist with Kis of 17 nM, 27 nM and 100 nM for 5-HT1D, 5-HT1B and 5-HT1A receptors, respectively. Sumatriptan succinate can be used for migraine headache research.
    Sumatriptan-d<sub>6</sub> succinate
  • HY-10158S
    Bosutinib-d8
    ≥99.0%
    Bosutinib-d8 is a deuterium labeled Bosutinib. Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively.
    Bosutinib-d<sub>8</sub>
  • HY-146945S
    Arachidonoyl LPA-d5
    Arachidonoyl LPA-d5 is deuterium labeled Arachidonoyl LPA.
    Arachidonoyl LPA-d<sub>5</sub>
  • HY-B1178S1
    (Rac)-Cotinine-d4
    99.56%
    (Rac)-Cotinine-d4 is the deuterium labeled (Rac)-Cotinine.
    (Rac)-Cotinine-d<sub>4</sub>
  • HY-137083S
    Trifluoperazine N-glucuronide-d3
    Trifluoperazine N-glucuronide-d3 is deuterium labeled Trifluoperazine N-Glucuronide. Trifluoperazine N-Glucuronide (UGT1A4), as one of the human UGT1A isoforms, is expressed in the liver. Trifluoperazine N-Glucuronide catalyzes the imipramine and trifluoperazine Nglucuronide formation.
    Trifluoperazine N-glucuronide-d<sub>3</sub>
  • HY-B0464S
    Hydralazine-d4 (hydrochloride)
    Hydralazine-d4 hydrochloride is the deuterium labeled Hydralazine hydrochloride. Hydralazine hydrochloride is an orally active, blood-brain barrier-permeable DNA methyltransferase inhibitor with vasodilatory, arterial smooth muscle relaxant and hypotensive activities. Hydralazine hydrochloride reactivates silenced tumor suppressor genes via mediating DNA demethylation, while exerting neuroprotective and anti-inflammatory properties. Hydralazine hydrochloride inhibits NOS-2 (iNOS) and COX-2, and reduces the production of NO and PGEE2; meanwhile, Hydralazine hydrochloride scavenges reactive oxygen species and inhibits macrophage activation. Hydralazine hydrochloride alleviates motor dysfunction, neuropathic inflammatory pain, and formalin-induced somatic and emotional pain responses. In addition, Hydralazine hydrochloride directly induces DNA strand breaks and sister chromatid exchange, exhibiting certain mutagenic characteristics. Hydralazine hydrochloride has been widely used in studies on hypertension, various cancers (such as cervical cancer, leukemia), spinal cord injury and the mechanisms of inflammatory pain.
    Hydralazine-d<sub>4</sub> (hydrochloride)
  • HY-W012908S
    DL-Proline-d7
    98.0%
    DL-Proline-d7 is the deuterium labeled DL-Proline (HY-W012908). H-DL-Pro-OH is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    DL-Proline-d<sub>7</sub>
  • HY-W745057
    N1,N12-Diacetylspermine-d6 dihydrochloride
    N1,N12-Diacetylspermine-d6 (DiAcSpm-d6) dihydrochloride is the deuterium labeled N1,N12-Diacetylspermine dihydrochloride (HY-113374A).
    N1,N12-Diacetylspermine-d<sub>6</sub> dihydrochloride
  • HY-78131S3
    Ibuprofen-13C6
    98.24%
    Ibuprofen-13C6 ((±)-Ibuprofen-13C6) is a 13C labeled Ibuprofen (HY-78131). Ibuprofen ((±)-Ibuprofen) is a potent, orally active, selective COX-1 inhibitor with an IC50 value of 13 μM. Ibuprofen inhibits cell proliferation, angiogenesis, and induces cell apoptosis. Ibuprofen is a nonsteroidal anti-inflammatory agent and a nitric oxide (NO) donor. Ibuprofen ((±)-Ibuprofen) can be used in the research of pain, swelling, inflammation, infection, immunology, cancers.
    Ibuprofen-<sup>13</sup>C<sub>6</sub>
  • HY-N6614S1
    L-Galactose-13C-1
    99.90%
    L-Galactose-13C-1 is the 13C labeled L-Galactose.
    L-Galactose-<sup>13</sup>C-1
  • HY-119980S
    Fluphenazine-d8
    99.12%
    Fluphenazine-d8 is the deuterium labeled Fluphenazine. Fluphenazine is a potent, orally active phenothiazine-based dopamine receptor antagonist. Fluphenazine blocks neuronal voltage-gated sodium channels. Fluphenazine acts primarily through antagonism of postsynaptic dopamine-2 receptors in mesolimbic, nigrostriatal, and tuberoinfundibular neural pathways. Fluphenazine can antagonize Methylphenidate-induced stereotyped gnawing and inhibit climbing behaviour in mice. Fluphenazine can be used for researching psychosis and painful peripheral neuropathy associated with diabetes and has potential to inhibit SARS-CoV-2.
    Fluphenazine-d<sub>8</sub>